ITI Securities Broking Ltd

Change Company Name

Jubilant Pharmova Ltd

Pharmaceuticals - Indian - Bulk Drugs

BSE Code 530019	ISIN Demat INE700A01033	Book Value 145.16	NSE Symbol JUBLPHARMA	Div & Yield % 0.52	Market Cap (₹ Cr.) 15,335.81	P/E 216.34	EPS 4.45	Face Value 1

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025
	₹ Cr	₹ Cr	₹ Cr	₹ Cr
Gross Sales	67.10	70.30	67.30	66.30
Other Operating Income	0.00	0.00	0.00	0.10
Other Income	0.10	0.50	0.40	42.40
Total Income	67.20	70.80	67.70	108.80
Total Expenditure	55.10	64.50	55.10	54.60
PBIDT	12.10	6.30	12.60	54.20
Interest	0.90	0.90	0.90	2.50
PBDT	11.20	5.40	11.70	51.70
Depreciation	1.40	1.30	1.60	1.60
Tax	2.00	0.20	1.80	1.40
Fringe Benefit Tax	0.00	0.00	0.00	0.00
Deferred Tax	0.50	-53.30	1.70	55.10
Reported Profit After Tax	7.30	57.20	6.60	-6.40
Extra-ordinary Items	0.00	-8.50	0.00	41.60
Adjusted Profit After Extra-ordinary item	7.30	65.70	6.60	-48.00

EPS (Unit Curr.)	0.46	3.59	0.42	-0.40
EPS (Adj) (Unit Curr.)	0.46	3.59	0.42	-0.40
Calculated EPS (Unit Curr.)	0.46	3.60	0.42	-0.40
Calculated EPS (Adj) (Unit Curr.)	0.46	3.60	0.42	-0.40
Calculated EPS (Ann.) (Unit Curr.)	1.84	14.39	1.66	-1.61
Calculated EPS (Adj) (Ann.) (Unit Curr.)	1.84	14.39	1.66	-1.61
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00
Equity	15.90	15.90	15.90	15.90
Reserve & Surplus	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00

PBIDTM(%)	18.03	8.96	18.72	81.75
PBDTM(%)	16.69	7.68	17.38	77.98
PATM(%)	10.88	81.37	9.81	-9.65
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00
Diluted EPS	0.46	3.59	0.42	-0.40

Quarterly Results

Market

News

Research

TECHNICAL

FUNDAMENTAL

Products

Attention Investors